Malignant mesothelioma: predictors of prognosis and clinical trials
The prognostic scoring systems used were the European Organization for Research and Treatment of Cancer (EORTC) system 11 and the US Cancer and Leukemia Group B (CALGB) system. 12 The EORTC system defines a high risk group of patients according to several factors: poor performance status, high white...
Saved in:
Published in | Thorax Vol. 55; no. 9; pp. 725 - 726 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group Ltd and British Thoracic Society
01.09.2000
BMJ Publishing Group LTD BMJ Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The prognostic scoring systems used were the European Organization for Research and Treatment of Cancer (EORTC) system 11 and the US Cancer and Leukemia Group B (CALGB) system. 12 The EORTC system defines a high risk group of patients according to several factors: poor performance status, high white blood cell count at diagnosis, probable or possible (uncertain) histology, male sex, and sarcomatous cell type. Poor prognosis factors by multivariate analysis of the Leicester patients were sarcomatous cell type, low haemoglobin, high white blood cell count, poor performance status, and male sex. |
---|---|
Bibliography: | href:thoraxjnl-55-725-2.pdf istex:FA28E9F017D094A0EA435227DE91C3FEFB0D1D32 ark:/67375/NVC-XQ4KB5GT-Q local:thoraxjnl;55/9/725a PMID:10950886 SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Feature-1 ObjectType-Editorial-4 ObjectType-Commentary-3 |
ISSN: | 0040-6376 1468-3296 |
DOI: | 10.1136/thorax.55.9.725a |